Dr. Kerrigan attended college at the University of California, Berkeley, and earned his medical degree from the University of California, San Francisco, where he also completed his residency in the Department of Pediatrics. Dr. Kerrigan completed a pediatric neurology residency at the University of California at Los Angeles before coming to the Barrow Neurological Institute for a fellowship in clinical neurophysiology and epilepsy.
Dr. Kerrigan's clinical interests include seizure monitoring and surgical treatment for epilepsy. His areas of expertise include the medical treatment of epilepsy, evaulation for epilepsy surgery, video-EEG epilepsy monitoring, and management of hypothalamic hamartomas. Dr. Kerrigan is the Research Director for the Hypothalamic Hamartoma (HH) Program at Barrow, which includes multiple clinical and laboratory collaborators, examining treatment outcome and the basic cellular mechanisms responsible for seizure activity in HH tissue.
He is the principal investigator in the Hypothalamic Hamartoma Tissue Research Laboratory, which is utilizing confocal microscopy with intracellular labeling and immunohistochemistry to study the microanatomy of HH tissue.
Dr. Kerrigan is an author or co-author of more than 50 papers for peer-reviewed publication. Within the last year, Dr. Kerrigan has been invited as a visiting professor at The Mayo Clinic in Rochester, Minnesota and Nationwide Children’s Hospital in Columbus, Ohio.
- International League against Epilepsy (ILAE), Pediatric Epilepsy Surgery Workgroup
- President Medical Advisory Board, Hope for Hypothalamic Hamartoma 501(c)3 Foundation
- Academic Promotions and Tenure Committee, Department of Child Health, University of Arizona - College of Medicine
- Associate Professor of Clinical Pediatrics and Neurology, University of Arizona - College of Medicine
Interests and Hobbies
In his free time, Dr. Kerrigan enjoys reading and gardening. Read Dr. Kerrigan's complete personal bio.